Search Results - "Dillon, Stacey R"
-
1
A sensory neuron–expressed IL-31 receptor mediates T helper cell–dependent itch: Involvement of TRPV1 and TRPA1
Published in Journal of allergy and clinical immunology (01-02-2014)“…Background Although the cytokine IL-31 has been implicated in inflammatory and lymphoma-associated itch, the cellular basis for its pruritic action is yet…”
Get full text
Journal Article -
2
The pruritus- and TH2-associated cytokine IL-31 promotes growth of sensory nerves
Published in Journal of allergy and clinical immunology (01-08-2016)“…Pruritus is a cardinal symptom of atopic dermatitis, and an increased cutaneous sensory network is thought to contribute to pruritus. Although the immune…”
Get full text
Journal Article -
3
RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications
Published in Journal of allergy and clinical immunology (01-05-2015)“…Background Genomic profiling of lesional and nonlesional skin of patients with atopic dermatitis (AD) using microarrays has led to increased understanding of…”
Get full text
Journal Article -
4
Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL
Published in The Journal of immunology (1950) (15-03-2008)“…Memory B (B(MEM)) cells and long-lived bone marrow plasma cells (BM-PCs) persist within local environmental survival niches that afford cellular longevity…”
Get full text
Journal Article -
5
IL-31-Driven Skin Remodeling Involves Epidermal Cell Proliferation and Thickening That Lead to Impaired Skin-Barrier Function
Published in PloS one (24-08-2016)“…Interleukin-31 (IL-31) is a type 2 helper T-cell-derived cytokine that has recently been shown to cause severe inflammation and tissue remodeling in multiple…”
Get full text
Journal Article -
6
The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity
Published in Nature communications (04-04-2022)“…Despite the recent clinical success of T cell checkpoint inhibition targeting the CTLA-4 and PD-1 pathways, many patients either fail to achieve objective…”
Get full text
Journal Article -
7
Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models
Published in Arthritis research & therapy (05-01-2022)“…Uncontrolled immune response with T cell activation has a key role in the pathogenesis of systemic sclerosis (SSc), a disorder that is characterized by…”
Get full text
Journal Article -
8
Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models
Published in Oncoimmunology (02-01-2018)“…Recent advances in cancer treatment with checkpoint blockade of receptors such as CTLA-4 and PD-1 have demonstrated that combinations of agents with…”
Get full text
Journal Article -
9
Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL
Published in Blood (15-01-2007)“…Hodgkin lymphoma (HL) originates from the clonal expansion of malignant Hodgkin and Reed-Sternberg (HRS) cells. These B-cell–derived elements constitute less…”
Get full text
Journal Article -
10
Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytes
Published in Blood (12-01-2012)“…In rodent graft-versus-host disease (GVHD) models, anti–IL-21 neutralizing mAb treatment ameliorates lethality and is associated with decreases in Th1 cytokine…”
Get full text
Journal Article -
11
IL-31 receptor (IL-31RA) knockout mice exhibit elevated responsiveness to oncostatin M
Published in The Journal of immunology (1950) (15-11-2010)“…IL-31 signals through the heterodimeric receptor IL-31RA and oncostatin M receptor (OSMR), and has been linked with the development of atopic dermatitis, a Th2…”
Get full text
Journal Article -
12
Novel Immunomodulatory Proteins Generated via Directed Evolution of Variant IgSF Domains
Published in Frontiers in immunology (21-01-2020)“…Immunoglobulin superfamily member (IgSF) proteins play a significant role in regulating immune responses with surface expression on all immune cell subsets,…”
Get full text
Journal Article -
13
The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency
Published in Journal of allergy and clinical immunology (01-12-2010)“…Background TNFRSF13B , which encodes transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), is mutated in 10% of patients with…”
Get full text
Journal Article -
14
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
Published in Nature (London) (27-04-2000)“…B cells are important in the development of autoimmune disorders by mechanisms involving disregulated polyclonal B-cell activation, production of pathogenic…”
Get full text
Journal Article -
15
Correction: IL-31-Driven Skin Remodeling Involves Epidermal Cell Proliferation and Thickening That Lead to Impaired Skin-Barrier Function
Published in PloS one (23-01-2017)“…[This corrects the article DOI: 10.1371/journal.pone.0161877.]…”
Get full text
Journal Article -
16
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function
Published in Nature (London) (02-11-2000)“…Cytokines are important in the regulation of haematopoiesis and immune responses, and can influence lymphocyte development. Here we have identified a class I…”
Get full text
Journal Article -
17
Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation
Published in Journal of allergy and clinical immunology (01-09-2011)“…Background B cells receive activating signals from T cells through CD40, from microbial DNA through Toll-like receptor (TLR) 9, and from dendritic cells…”
Get full text
Journal Article -
18
Functional analysis of transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) mutations associated with common variable immunodeficiency
Published in Journal of allergy and clinical immunology (01-07-2011)“…Signaling by the intracellular domain mutants (K188M and V246F) was intact. Because TACI assembles as a trimer or higher-order oligomer,6 TACI mutants with…”
Get full text
Journal Article -
19
A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase–regulated mammalian target of rapamycin activation
Published in Blood (21-05-2009)“…A proliferation-inducing ligand (APRIL), as well as its receptors transmembrane activator and calcium-modulating cyclophilin ligand (CAML) interactor (TACI)…”
Get full text
Journal Article -
20
Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation
Published in Autoimmunity (Chur, Switzerland) (01-03-2011)“…B lymphocyte stimulator (BLyS) and APRoliferation inducing ligand (APRIL) are members of the TNF superfamily that regulate B-cell survival and autoreactivity…”
Get full text
Journal Article